ESAP1 ESAP Live - Diabetes, Lipids / Obesity, and Pituitary

Program: ESAP Live
Clinical Session
Friday, April 1, 2016: 1:30 PM-3:00 PM
Room 153 (BCEC)
Speakers:
Jennifer Brigitte Green, MD, Durham Veterans Affairs Medical Center, Durham, NC , Thomas Walter Donner, Johns Hopkins, Baltimore, MD , Maria L Collazo-Clavell, MD, Mayo Clinic, Rochester, MN , Nicholas A Tritos, DSc, MD, Massachusetts General Hospital/Harvard Medical School, Boston, MA , Adrian Vella, MD, Mayo Clinic, Rochester, MN and Marie Freel, University of Glasgow, Glasgow,
Moderator:
Lisa R Tannock, MD, University of Kentucky, Lexington, KY

Disclosures:
TWD: Principal Investigator, Novo Nordisk. NAT: Researcher, Ipsen, Researcher, Pfizer, Inc., Researcher, Novo Nordisk, Wife is an employee, Pfizer, Inc.. AV: Consultant, Sanofi. Nothing to Disclose: LRT, MLC, MF Disclosure Not Provided: JBG

ESAP Live returns to ENDO by popular demand. Pre-order ESAP 2016 at a discounted rate and attend these live sessions to learn directly from the authors of the latest edition of ESAP 2016, an ABIM-approved MOC activity.

In addition to AMA PRA Category 1 Credits, this session will be approved for ABIM MOC Medical Knowledge Assessment points.

See more of: ESAP Live

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire